159 related articles for article (PubMed ID: 19840258)
1. Risk of pancreatic cancer in chronic hepatitis B virus infection: data from the REVEAL-HBV cohort study.
Iloeje UH; Yang HI; Jen CL; Su J; Wang LY; You SL; Lu SN; Chen CJ
Liver Int; 2010 Mar; 30(3):423-9. PubMed ID: 19840258
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
3. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.
Chen JD; Yang HI; Iloeje UH; You SL; Lu SN; Wang LY; Su J; Sun CA; Liaw YF; Chen CJ;
Gastroenterology; 2010 May; 138(5):1747-54. PubMed ID: 20114048
[TBL] [Abstract][Full Text] [Related]
4. Natural history of chronic hepatitis B REVEALed.
Chen CJ; Yang HI
J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
[TBL] [Abstract][Full Text] [Related]
5. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study.
Liu J; Yang HI; Lee MH; Lu SN; Jen CL; Wang LY; You SL; Iloeje UH; Chen CJ;
Gastroenterology; 2010 Aug; 139(2):474-82. PubMed ID: 20434450
[TBL] [Abstract][Full Text] [Related]
6. Risk and predictors of mortality associated with chronic hepatitis B infection.
Iloeje UH; Yang HI; Jen CL; Su J; Wang LY; You SL; Chen CJ;
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):921-31. PubMed ID: 17678844
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan.
Fwu CW; Chien YC; You SL; Nelson KE; Kirk GD; Kuo HS; Feinleib M; Chen CJ
Hepatology; 2011 Apr; 53(4):1217-25. PubMed ID: 21480326
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B e antigen and the risk of hepatocellular carcinoma.
Yang HI; Lu SN; Liaw YF; You SL; Sun CA; Wang LY; Hsiao CK; Chen PJ; Chen DS; Chen CJ;
N Engl J Med; 2002 Jul; 347(3):168-74. PubMed ID: 12124405
[TBL] [Abstract][Full Text] [Related]
9. Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma.
Chen CF; Lee WC; Yang HI; Chang HC; Jen CL; Iloeje UH; Su J; Hsiao CK; Wang LY; You SL; Lu SN; Chen CJ;
Gastroenterology; 2011 Oct; 141(4):1240-8, 1248.e1-2. PubMed ID: 21703214
[TBL] [Abstract][Full Text] [Related]
10. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
[TBL] [Abstract][Full Text] [Related]
11. Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Yang HI; Sherman M; Su J; Chen PJ; Liaw YF; Iloeje UH; Chen CJ
J Clin Oncol; 2010 May; 28(14):2437-44. PubMed ID: 20368541
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.
Yu MW; Yeh SH; Chen PJ; Liaw YF; Lin CL; Liu CJ; Shih WL; Kao JH; Chen DS; Chen CJ
J Natl Cancer Inst; 2005 Feb; 97(4):265-72. PubMed ID: 15713961
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
Chen CH; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
[TBL] [Abstract][Full Text] [Related]
14. Low HBV-DNA levels in end-stage renal disease patients with HBeAg-negative chronic hepatitis B.
Moutinho RS; Perez RM; Medina-Pestana JO; Figueiredo MS; Koide S; Alberto FL; Silva AE; Ferraz ML
J Med Virol; 2006 Oct; 78(10):1284-8. PubMed ID: 16927290
[TBL] [Abstract][Full Text] [Related]
15. The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses.
Wang CS; Yao WJ; Chang TT; Wang ST; Chou P
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2054-60. PubMed ID: 19549812
[TBL] [Abstract][Full Text] [Related]
16. The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: association with liver disease progression. A prospective cohort study.
Zacharakis G; Koskinas J; Kotsiou S; Tzara F; Vafeiadis N; Papoutselis M; Maltezos E; Sivridis E; Papoutselis K
J Hepatol; 2008 Dec; 49(6):884-91. PubMed ID: 18674840
[TBL] [Abstract][Full Text] [Related]
17. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
[TBL] [Abstract][Full Text] [Related]
18. The long-term course of chronic hepatitis B.
Di Marco V; Lo Iacono O; Cammà C; Vaccaro A; Giunta M; Martorana G; Fuschi P; Almasio PL; Craxì A
Hepatology; 1999 Jul; 30(1):257-64. PubMed ID: 10385664
[TBL] [Abstract][Full Text] [Related]
19. Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project).
Zacharakis GH; Koskinas J; Kotsiou S; Papoutselis M; Tzara F; Vafeiadis N; Archimandritis AJ; Papoutselis K
J Med Virol; 2005 Oct; 77(2):173-9. PubMed ID: 16121378
[TBL] [Abstract][Full Text] [Related]
20. Mortality after chronic hepatitis B virus infection: a linkage study involving 2 million parous women from Taiwan.
Fwu CW; Chien YC; Nelson KE; Kirk GD; You SL; Kuo HS; Feinleib M; Chen CJ
J Infect Dis; 2010 Apr; 201(7):1016-23. PubMed ID: 20187745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]